株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生命科学分野におけるアナリティクスの市場: 〜2021年:タイプ (記述的・処方的アナリティクス)・用途 (マーケティング・R&D・法令遵守・SCM)・コンポーネント (ソフトウェア・サービス)・デリバリー・エンドユーザー別

Life Science Analytics Market by Type (Descriptive, Prescriptive), Application (Marketing, R&D, Compliance, SCM), Component (Software, Service), Delivery (On premise, Cloud), End user (Pharmaceutical, Biotechnology, & Others) - Forecasts to 2021

発行 MarketsandMarkets 商品コード 424447
出版日 ページ情報 英文 179 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.47円で換算しております。
Back to Top
生命科学分野におけるアナリティクスの市場: 〜2021年:タイプ (記述的・処方的アナリティクス)・用途 (マーケティング・R&D・法令遵守・SCM)・コンポーネント (ソフトウェア・サービス)・デリバリー・エンドユーザー別 Life Science Analytics Market by Type (Descriptive, Prescriptive), Application (Marketing, R&D, Compliance, SCM), Component (Software, Service), Delivery (On premise, Cloud), End user (Pharmaceutical, Biotechnology, & Others) - Forecasts to 2021
出版日: 2017年01月20日 ページ情報: 英文 179 Pages
概要

世界の生命科学分野におけるアナリティクスの市場は2016年から2021年にかけて13.3%のCAGR (年間複合成長率) で推移し、2016年の132億6000万米ドルから、2021年には247億3000万米ドルの規模に成長すると予測されています。技術的進歩やビッグデータのアベイラビリティ、臨床試験や販売&マーケティング部門におけるアナリティクスソリューションの導入拡大、データの標準化に対するニーズの高まりなどの要因が同市場の成長を推進しています。

当レポートでは、生命科学分野におけるアナリティクスの市場を調査し、市場およびソリューションの概要、市場成長への各種影響因子と市場機会の分析、用途・コンポーネント・デリバリーモデル・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • タイプ別市場
  • 用途別市場
  • コンポーネント別市場
  • デリバリーモデル別市場
  • エンドユーザー別市場
  • 地域概要

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 成長促進因子
    • 成長抑制因子
    • 市場機会
    • 課題

第6章 市場分析:タイプ別

  • イントロダクション
  • 記述的アナリティクス
  • 予測的アナリティクス
  • 処方的アナリティクス

第7章 市場分析:用途別

  • イントロダクション
  • R&D
    • 前臨床試験
    • 臨床試験
  • 販売・マーケティング支援
  • 法令順守
  • サプライチェーンアナリティクス
  • ファーマコビジランス

第8章 市場分析:コンポーネント別

  • イントロダクション
  • サービス
  • ソフトウェア

第9章 市場分析:デリバリーモデル別

  • イントロダクション
  • オンプレミス
  • オンデマンド

第10章 市場分析:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 医療機器企業
  • 研究センター
  • サードパーティ

第11章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他
  • アジア
  • その他の地域

第12章 競合環境

  • 概要
  • 市場分析
  • 競合状況・動向
    • 製品・サービスの投入・アップグレード・強化
    • 提携・合意・協力
    • 拡張
    • M&A

第13章 企業プロファイル

  • イントロダクション
  • SAS INSTITUTE INC.
  • IBM CORPORATION
  • ORACLE CORPORATION
  • QUINTILES, INC.
  • ACCENTURE
  • COGNIZANT
  • MAXISIT
  • SCIO HEALTH ANALYTICS
  • TAKE SOLUTIONS
  • WIPRO LIMITED
    • イントロダクション
    • 製品・サービス
    • 戦略
    • アナリストの見解、など

第14章 付録

図表

目次
Product Code: HIT 4869

The global life science analytics market is expected to reach USD 24.73 billion by 2021 from USD 13.26 billion in 2016, at a CAGR of 13.3% from 2016 to 2021.

Major factors contributing to the growth of the global life science analytics market include technological advancements, availability of big data in the life science industry, growing adoption of analytics solutions for clinical trials, increasing adoption of analytics solutions for sales and marketing applications, growing need for improved data standardization, rising prevalence of chronic diseases, increasing pressure to curb healthcare spending, and growing need for improved patient outcomes. Moreover, increasing focus on value-based medicine, use of analytics in precision and personalized medicine, cloud-based analytics, use of big data analytics to increase R&D productivity, and emergence of social media and its impact on the life science industry provide significant growth opportunities in the market. However, lack of skilled professionals and financial constraints may hinder the growth of this market during the forecast period.

Various companies are focusing on technological advancements to improve the life science industry. Life science companies are increasingly adopting digitization in order to increase productivity and profitability. To leverage growth opportunities many of the players in the market are innovating and upgrading their portfolios. For instance, in April 2016, Oracle Corporation (U.S.) launched the cloud version of its Oracle Health Sciences Safety Suite 8.0. This solution provides end-to-end safety management and business analytics/intelligence to pharma companies.

Asia is projected to be fastest-growing region in the market during the forecast period. High growth in this region can be attributed to factors such as large population base, growing prevalence of chronic diseases, increasing need for innovative therapies, and low manufacturing costs in the region. Moreover, growing focus on the adoption of digital technology in life science manufacturing and R&D activities is expected to boost the life science analytics market in Asia.

Research Coverage:

This market is categorized on the basis of type, application, component, delivery model, end user, and region. Apart from comprehensive geographical analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The abovementioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the life science analytics market. The report analyzes this market by type, application, component, delivery model, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the life science analytics market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the life science analytics market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for life science analytics across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the life science analytics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY INDUSTRY INSIGHTS
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. LIFE SCIENCE ANALYTICS MARKET OVERVIEW
  • 4.2. LIFE SCIENCE ANALYTICS MARKET, BY TYPE
  • 4.3. LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION
  • 4.4. LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT
  • 4.5. LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL
  • 4.6. LIFE SCIENCE ANALYTICS MARKET, BY END USER
  • 4.7. GEOGRAPHIC SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Technological advancements
      • 5.2.1.2. Availability of big data in the life science industry
      • 5.2.1.3. Growing adoption of analytics solutions in clinical trials
      • 5.2.1.4. Increasing adoption of analytics for sales and marketing applications
      • 5.2.1.5. Need for improved data standardization
      • 5.2.1.6. Increasing prevalence of chronic diseases
      • 5.2.1.7. Growing pressure to curb healthcare spending and the need for improved patient outcomes
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Dearth of skilled personnel
      • 5.2.2.2. High implementation costs
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing focus on value-based medicine
      • 5.2.3.2. Use of analytics in precision and personalized medicine
      • 5.2.3.3. Cloud-based analytics
      • 5.2.3.4. Use of big data analytics to increase R&D productivity
      • 5.2.3.5. Emergence of social media and its impact on the life science industry
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Data privacy issues
      • 5.2.4.2. Data integration in the life science ecosystem

6. LIFE SCIENCE ANALYTICS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. DESCRIPTIVE ANALYTICS
  • 6.3. PREDICTIVE ANALYTICS
  • 6.4. PRESCRIPTIVE ANALYTICS

7. LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESEARCH AND DEVELOPMENT
    • 7.2.1. PRECLINICAL TRIALS
    • 7.2.2. CLINICAL TRIALS
  • 7.3. SALES AND MARKETING SUPPORT
  • 7.4. REGULATORY COMPLIANCE
  • 7.5. SUPPLY CHAIN ANALYTICS
  • 7.6. PHARMACOVIGILANCE

8. LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT

  • 8.1. INTRODUCTION
  • 8.2. SERVICES
  • 8.3. SOFTWARE

9. LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL

  • 9.1. INTRODUCTION
  • 9.2. ON-PREMISE DELIVERY MODELS
  • 9.3. ON-DEMAND DELIVERY MODELS

10. LIFE SCIENCE ANALYTICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 10.3. MEDICAL DEVICE COMPANIES
  • 10.4. RESEARCH CENTERS
  • 10.5. THIRD-PARTY ADMINISTRATORS

11. LIFE SCIENCE ANALYTICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. REST OF EUROPE
  • 11.4. ASIA
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. PRODUCT AND SERVICE LAUNCHES, UPGRADES, AND ENHANCEMENTS
    • 12.3.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 12.3.3. EXPANSIONS
    • 12.3.4. MERGERS AND ACQUISITIONS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. SAS INSTITUTE INC.
  • 13.3. IBM CORPORATION
  • 13.4. ORACLE CORPORATION
  • 13.5. QUINTILES, INC.
  • 13.6. ACCENTURE
  • 13.7. COGNIZANT
  • 13.8. MAXISIT
  • 13.9. SCIO HEALTH ANALYTICS
  • 13.10. TAKE SOLUTIONS
  • 13.11. WIPRO LIMITED

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT
  • TABLE 2: RECENT PRODUCT LAUNCHES
  • TABLE 3: ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS AND TECHNOLOGICAL ADVANCEMENTS ARE MAJOR DRIVERS FOR MARKET GROWTH
  • TABLE 4: DEARTH OF SKILLED PERSONNEL IS A MAJOR RESTRAINT FOR MARKET GROWTH
  • TABLE 5: RECENT DEVELOPMENTS IN PERSONALIZED MEDICINE
  • TABLE 6: INCREASING FOCUS ON VALUE-BASED MEDICINE IS A MAJOR OPPORTUNITY FOR MARKET GROWTH
  • TABLE 7: DATA PRIVACY IS A MAJOR CHALLENGE
  • TABLE 8: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 9: DESCRIPTIVE ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: EUROPE: DESCRIPTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: PREDICTIVE ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: NORTH AMERICA: PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: EUROPE: PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: PRESCRIPTIVE ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: EUROPE: PRESCRIPTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 19: RESEARCH AND DEVELOPMENT ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: NORTH AMERICA: RESEARCH AND DEVELOPMENT ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: EUROPE: RESEARCH AND DEVELOPMENT ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: RESEARCH AND DEVELOPMENT ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 23: PRECLINICAL TRIAL ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: PRECLINICAL TRIAL ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: EUROPE: PRECLINICAL TRIAL ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: CLINICAL TRIAL ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CLINICAL TRIAL ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: EUROPE: CLINICAL TRIAL ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: SALES AND MARKETING ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: SALES AND MARKETING ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: EUROPE: SALES AND MARKETING ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: REGULATORY COMPLIANCE ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NORTH AMERICA: REGULATORY COMPLIANCE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: EUROPE: REGULATORY COMPLIANCE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: SUPPLY CHAIN ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: NORTH AMERICA: SUPPLY CHAIN ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: SUPPLY CHAIN ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: PHARMACOVIGILANCE ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: PHARMACOVIGILANCE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: EUROPE: PHARMACOVIGILANCE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 42: LIFE SCIENCE ANALYTICS SERVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: LIFE SCIENCE ANALYTICS SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 49: ON-PREMISE DELIVERY MODELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: ON-PREMISE DELIVERY MODELS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: ON-PREMISE DELIVERY MODELS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: ON-DEMAND DELIVERY MODELS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: ON-DEMAND DELIVERY MODELS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: EUROPE: ON-DEMAND DELIVERY MODELS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 56: LIFE SCIENCE ANALYTICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: LIFE SCIENCE ANALYTICS MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 62: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 63: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 65: LIFE SCIENCE ANALYTICS MARKET SIZE FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 66: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 67: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: LIFE SCIENCE ANALYTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 69: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 71: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 74: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 75: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 76: U.S.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: U.S.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 78: U.S.: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: U.S.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 80: U.S.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 81: U.S.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 82: CANADA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: CANADA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 84: CANADA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: CANADA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 86: CANADA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 87: CANADA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 88: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 89: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 91: EUROPE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92 : UROPE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 93 : UROPE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 94 : UROPE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 95 : ERMANY: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96 : ERMANY: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97 : ERMANY: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98 : ERMANY: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 99 : ERMANY: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 100: GERMANY: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 101: FRANCE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: FRANCE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 103: FRANCE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: FRANCE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 105: FRANCE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 106: FRANCE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 107: U.K.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 108: U.K.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 109: U.K.: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: U.K.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 111: U.K.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 112: U.K.: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 113: ROE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 114: ROE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 115: ROE: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 116: ROE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 117: ROE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 118: ROE: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER,
  • TABLE 119: ASIA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 120: ASIA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 121: ASIA: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 122: ASIA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 123: ASIA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 124: ASIA: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 125: ROW: LIFE SCIENCE ANALYTICS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: ROW: LIFE SCIENCE ANALYTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 127: ROW: LIFE SCIENCE ANALYTICS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 128: ROW: LIFE SCIENCE ANALYTICS MARKET SIZE, BY COMPONENT, 2014-2021 (USD MILLION)
  • TABLE 129: ROW: LIFE SCIENCE ANALYTICS MARKET SIZE, BY DELIVERY MODEL, 2014-2021 (USD MILLION)
  • TABLE 130: ROW: LIFE SCIENCE ANALYTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 131: LIFE SCIENCE ANALYTICS MARKET RANKING, BY KEY PLAYER, 2015
  • TABLE 132: PRODUCT AND SERVICE LAUNCHES, UPGRADES, AND ENHANCEMENTS (2013-2016)
  • TABLE 133: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2013-2016)
  • TABLE 134: EXPANSIONS (2013-2016)
  • TABLE 135: MERGERS AND ACQUISITIONS (2013-2016)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION : BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 7: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 8: DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE THE MARKET, BY TYPE, DURING THE FORECAST PERIOD
  • FIGURE 9: SALES AND MARKETING SUPPORT SEGMENT TO REGISTER THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 10: SERVICES SEGMENT TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 11: ON-DEMAND DELIVERY MODEL TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 12: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES FORM MAJOR END USERS OF LIFE SCIENCE ANALYTICS
  • FIGURE 13: ASIA TO REGISTER THE HIGHEST GROWTH IN THE LIFE SCIENCE ANALYTICS MARKET DURING 2016-2021
  • FIGURE 14: TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS ARE DRIVING MARKET GROWTH
  • FIGURE 15: DESCRIPTIVE AND PREDICTIVE ANALYTICS TO DOMINATE THE MARKET IN 2016
  • FIGURE 16: RESEARCH AND DEVELOPMENT SEGMENT FORMS THE LARGEST APPLICATION SEGMENT IN 2016
  • FIGURE 17: SERVICES SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 18: ON-DEMAND DELIVERY MODEL TO OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 19: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO HOLD THE LARGEST SHARE OF THE END USER MARKET IN 2016
  • FIGURE 20: ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 21: LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22: HEALTHCARE SPENDING, 2014 (% GDP)
  • FIGURE 23: PRESCRIPTIVE ANALYTICS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 24: DESCRIPTIVE ANALYTICS MARKET, BY REGION: ASIA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 25: SALES AND MARKETING SUPPORT ANALYTICS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 26: PRECLINICAL TRIALS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 27: THE SERVICES SEGMENT TO IS EXPECTED TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET FROM 2016 TO 2021
  • FIGURE 28: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE LIFE SCIENCE ANALYTICS SERVICES MARKET (2016-2021)
  • FIGURE 29: ON-DEMAND DELIVERY MODELS TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 30: ASIA TO GROW AT THE HIGHEST CAGR IN THE ON-PREMISE DELIVERY MODELS MARKET DURING THE FORECAST PERIOD
  • FIGURE 31: PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET IN THE FORECAST PERIOD
  • FIGURE 32: NORTH AMERICA TO DOMINATE THE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT DURING 2016-2021
  • FIGURE 33: NORTH AMERICA TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 34: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 35: EUROPE: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 36: ASIA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 37: ROW: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 38: KEY DEVELOPMENTS IN THE LIFE SCIENCE ANALYTICS MARKET, 2013-2016
  • FIGURE 39: MARKET EVOLUTION FRAMEWORK - PRODUCT & SERVICE LAUNCHES, UPGRADES, AND ENHANCEMENTS FUELED MARKET GROWTH (2013-2016)
  • FIGURE 40: BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES, SERVICE LAUNCHES, PRODUCT UPGRADES, PRODUCT ENHANCEMENTS AND SERVICE ENHANCEMENTS ARE THE KEY STRATEGIES ADOPTED BY MARKET PLAYERS
  • FIGURE 41: GEOGRAPHIC REVENUE MIX OF THE TOP 5 PLAYERS IN THE LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 42: COMPANY SNAPSHOT: SAS INSTITUTE INC.
  • FIGURE 43: COMPANY SNAPSHOT: IBM CORPORATION
  • FIGURE 44: COMPANY SNAPSHOT: ORACLE CORPORATION
  • FIGURE 45: COMPANY SNAPSHOT: QUINTILES, INC.
  • FIGURE 46: COMPANY SNAPSHOT: ACCENTURE
  • FIGURE 47: COMPANY SNAPSHOT: COGNIZANT
  • FIGURE 48: COMPANY SNAPSHOT: TAKE SOLUTIONS
  • FIGURE 49: COMPANY SNAPSHOT: WIPRO LIMITED
Back to Top